Correlation Between Sdiptech and Vitrolife

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sdiptech and Vitrolife at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sdiptech and Vitrolife into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sdiptech AB and Vitrolife AB, you can compare the effects of market volatilities on Sdiptech and Vitrolife and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sdiptech with a short position of Vitrolife. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sdiptech and Vitrolife.

Diversification Opportunities for Sdiptech and Vitrolife

-0.76
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Sdiptech and Vitrolife is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Sdiptech AB and Vitrolife AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vitrolife AB and Sdiptech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sdiptech AB are associated (or correlated) with Vitrolife. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vitrolife AB has no effect on the direction of Sdiptech i.e., Sdiptech and Vitrolife go up and down completely randomly.

Pair Corralation between Sdiptech and Vitrolife

Assuming the 90 days trading horizon Sdiptech AB is expected to generate 1.01 times more return on investment than Vitrolife. However, Sdiptech is 1.01 times more volatile than Vitrolife AB. It trades about 0.19 of its potential returns per unit of risk. Vitrolife AB is currently generating about 0.02 per unit of risk. If you would invest  10,670  in Sdiptech AB on April 24, 2025 and sell it today you would earn a total of  2,830  from holding Sdiptech AB or generate 26.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Sdiptech AB  vs.  Vitrolife AB

 Performance 
       Timeline  
Sdiptech AB 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Sdiptech AB are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Sdiptech reported solid returns over the last few months and may actually be approaching a breakup point.
Vitrolife AB 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Vitrolife AB are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Vitrolife is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Sdiptech and Vitrolife Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sdiptech and Vitrolife

The main advantage of trading using opposite Sdiptech and Vitrolife positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sdiptech position performs unexpectedly, Vitrolife can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vitrolife will offset losses from the drop in Vitrolife's long position.
The idea behind Sdiptech AB and Vitrolife AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data